Parion Sciences Company Profile: Valuation & Investors

Parion Sciences Overview

Founded
2000

Status
Private

Employees
18

Latest Deal Type
Grant

Latest Deal Amount
$3M

Investors
2

Parion Sciences General Information

Description

Operator of a development stage company dedicated to research, development, and commercialization of treatments for diseases with unmet medical needs. The company's technologies target respiratory, ocular, and other epithelial diseases resulting from the patient's ability to protect their mucosal surfaces is compromised, thereby enabling healthcare professionals to restore a patient's innate mucosal defense system.

Contact Information

Website

www.parion.com

Formerly Known As

CyFi Inc.

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

Suite 195
2800 Meridian Parkway
Durham, NC 27713
United States

+1 (919) 000-0000



Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parion Sciences Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Status	Stage
10. Grant	16-Sep-2014	$3M	000.00	Completed	Generating Revenue
9. Grant	01-Jan-2013	00.000	000.00	Completed	Startup
8. Grant	01-Jan-2011	00.00	000.00	Completed	Startup
7. Grant	01-Jan-2010	00000	000.00	Completed	Startup
6. Grant	01-Jan-2009	00000	000.00	Completed	Startup
5. Grant	01-Jan-2006	00000	000.00	Completed	Startup
4. Later Stage VC (Series C)	10-Jan-2005	000.00	000.00	Completed	Startup
3. Grant	01-Jan-2005	00000	000.00	Completed	Startup
2. Angel (individual)	07-Jul-2003	$3.57M	$10.1M	Completed	Startup
1. Angel (individual)	26-Nov-2002	$6.5M	$6.5M	Completed	Startup

To view Parion Sciences’s complete valuation and funding history, request access »

Parion Sciences Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Operator of a development stage company dedicated to research, development, and commercialization of treatments for dise

Drug Discovery

Durham, NC

18 As of 2020

000.00

0000000000 000.00

00 00000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur

0000000000000

Durham, NC

000 As of 0000

00000

000000 - 000 00000

00000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit

0000 000000000

Exton, PA

000 As of 0000

0000

0000 0000-00-00

000000&0 0000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parion Sciences Competitors (11)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
G1 Therapeutics	Formerly VC-backed	Durham, NC	000	00000	000000 - 000	00000
000000000	Formerly VC-backed	Exton, PA	000	0000	000000&0	0000
0000 000	Venture Capital-Backed	Durham, NC	00	000.00	00000000000	000.00
000000 00000	Private Equity-Backed	Durham, NC	00	00000	000000000000	00000
00000 000000000	Formerly VC-backed	Boulder, CO	000	00000	000000&0	00000

You’re viewing 5 of 11 competitors. Get the full list »

Parion Sciences Executive Team (5)

Name	Title	Board Seat	Contact Info
Paul Boucher	President, Chief Executive Officer & Board Member
Richard Boucher MD	Co-Founder & Co-Chairman
Ross Johnson Ph.D	Co-Founder & Co-Chairman
Alison Church MD	Chief Medical Officer

To view Parion Sciences’s complete executive team members history, request access »

Parion Sciences Board Members (4)

Name	Representing	Role
Paul Boucher	Parion Sciences	President, Chief Executive Officer & Board Member
Richard Boucher MD	Parion Sciences	Co-Founder & Co-Chairman
Robert Wills Ph.D	Self	Board Member
Ross Johnson Ph.D	Parion Sciences	Co-Founder & Co-Chairman